SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-016208
Filing Date
2023-10-03
Accepted
2023-10-03 16:05:35
Documents
14
Period of Report
2023-10-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K krbp-20231001x8k.htm   iXBRL 8-K 37645
2 EX-10.1 krbp-20231001xex10d1.htm EX-10.1 74595
3 GRAPHIC krbp-20231001xex10d1001.jpg GRAPHIC 14913
  Complete submission text file 0001558370-23-016208.txt   271929

Data Files

Seq Description Document Type Size
4 EX-101.SCH krbp-20231001.xsd EX-101.SCH 3130
5 EX-101.LAB krbp-20231001_lab.xml EX-101.LAB 16579
6 EX-101.PRE krbp-20231001_pre.xml EX-101.PRE 10532
8 EXTRACTED XBRL INSTANCE DOCUMENT krbp-20231001x8k_htm.xml XML 5027
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

IRS No.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39619 | Film No.: 231303511
SIC: 2836 Biological Products, (No Diagnostic Substances)